Praxis Precision Medicines, Inc.(PRAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PRAX Praxis Precision Medicines, Inc.

Post-Market Trading 03-18 16:14:47 EDT

36.82

-2.11

-5.42%

盘后36.78

-0.04-0.11%

16:10 EDT

High39.50	Low36.37	Vol418.44K
Open38.54	D1 Closing38.93	Amplitude8.04%
Mkt Cap742.41M	Tradable Cap629.65M	Total Shares20.16M
T/O15.57M	T/O Rate2.45%	Tradable Shares17.10M
P/B1.67	ROE-70.98%	EPS-10.21
52wk High91.83	52wk Low30.01	P/E-3.61
Dividend0.00	Div.Yield0.00	ROA-43.81%

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"PRAX","market":"US","secType":"STK","nameCN":"Praxis Precision Medicines, Inc.","latestPrice":36.82,"timestamp":1742328000000,"preClose":38.93,"halted":0,"volume":418441,"hourTrading":{"tag":"盘后","latestPrice":36.78,"preClose":36.82,"latestTime":"16:10 EDT","volume":6658,"amount":245147.42684,"timestamp":1742328611352},"delay":0,"floatShares":17100855,"shares":20163250,"eps":-10.209476,"marketStatus":"Post-Market Trading","change":-2.11,"latestTime":"03-18 16:14:45 EDT","open":38.54,"high":39.5,"low":36.37,"amount":15573256.782529999,"amplitude":0.080401,"askPrice":37.53,"askSize":45,"bidPrice":36.5,"bidSize":250,"shortable":3,"etf":0,"ttmEps":-10.209476,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1742342400000},"marketStatusCode":4,"adr":0,"listingDate":1602820800000,"exchange":"NASDAQ","adjPreClose":38.93,"preHourTrading":{"tag":"盘前","latestPrice":38.99,"preClose":38.93,"latestTime":"09:24 EDT","volume":888,"amount":34162.126344000004,"timestamp":1742304260596},"postHourTrading":{"tag":"盘后","latestPrice":36.78,"preClose":36.82,"latestTime":"16:10 EDT","volume":6658,"amount":245147.42684,"timestamp":1742328611352},"volumeRatio":1.068963,"impliedVol":0.8849,"impliedVolPercentile":0.256},"requestUrl":"/m/hq/s/PRAX","defaultTab":"news","newsList":[{"id":"1162846292","title":"Stock Track | Praxis Precision Medicines Plummets 5.4% Following Disappointing Q4 Earnings and Financial Update","url":"https://stock-news.laohu8.com/highlight/detail?id=1162846292","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162846292?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 22:38","pubTimestamp":1741271924,"startTime":"0","endTime":"0","summary":"Shares of Praxis Precision Medicines, Inc.  plummeted 5.4% in pre-market trading on Thursday, following the company's release of its fourth quarter 2024 earnings results and financial update on Wednesday evening.According to the earnings report, Praxis Precision Medicines reported weaker-than-expected revenue and wider losses for the quarter, missing analysts' estimates. The company also provided a gloomy outlook for its drug pipeline and clinical trial progress, citing delays and setbacks in so","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | Praxis Precision Medicines Plummets 5.4% Following Disappointing Q4 Earnings and Financial Update","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PRAX"],"gpt_icon":0},{"id":"2517190485","title":"Praxis Precision Medicines Updates on Programs and Finances","url":"https://stock-news.laohu8.com/highlight/detail?id=2517190485","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517190485?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 12:13","pubTimestamp":1741234402,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines, Inc. ( ($PRAX) ) has released its Q4 earnings. Here is a breakdown of the information Praxis Precision Medicines, Inc. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/praxis-precision-medicines-updates-on-programs-and-finances?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/praxis-precision-medicines-updates-on-programs-and-finances?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MDCO","PRAX"],"gpt_icon":0},{"id":"2517849469","title":"Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517849469","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517849469?lang=en_us&edition=full_marsco","pubTime":"2025-03-05 06:00","pubTimestamp":1741125600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nTUA49XRPT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRAX","BK4139"],"gpt_icon":0},{"id":"2517984265","title":"Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517984265","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517984265?lang=en_us&edition=full_marsco","pubTime":"2025-03-05 06:00","pubTimestamp":1741125600,"startTime":"0","endTime":"0","summary":"The 2024 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Praxis, or following a bona fide period of non-employment, as an inducement material to such individuals’ entering into employment with Praxis, pursuant to Nasdaq Listing Rule 5635.The options have an exercise price of $33.55 per share, which is equal to the closing price of Praxis’ common stock on the Nasdaq Global Select Market on the date of grant. The options will vest over four years, with 25% of the options vesting on the first anniversary of the vesting commencement date and the remaining options vesting in equal monthly installments over the three years thereafter, subject to each employee’s continued employment with Praxis on each vesting dates. The restricted stock units will vest in four equal annual installments, subject to each employee’s continued employment with Praxis on each vesting date.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/praxis-precision-medicines-inc-announces-220000054.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B3QW5Z07.USD","BK4585","BK4112","IE00B64PRP62.GBP","BK4588","PRAX","BK4139","BK4561","LU2210150020.SGD","IE00BKPKM429.USD",".IXIC","NDAQ","IE00BGHQF748.EUR","ASO","CNS","BK4200","LU2095319765.USD","LU2210149790.SGD","BK4135"],"gpt_icon":0},{"id":"2516067575","title":"Praxis Precision Medicines to Participate in Five Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2516067575","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516067575?lang=en_us&edition=full_marsco","pubTime":"2025-03-04 21:00","pubTimestamp":1741093200,"startTime":"0","endTime":"0","summary":"857-702-9452. Media Contact:. Dan Ferry. Life Science Advisors. Daniel@lifesci","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/04/3036474/0/en/Praxis-Precision-Medicines-to-Participate-in-Five-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","PRAX","MDCO","CNS","BK4139","BK4200","BK4561","ASO"],"gpt_icon":0},{"id":"2516631794","title":"Praxis Precision Medicines Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2516631794","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516631794?lang=en_us&edition=full_marsco","pubTime":"2025-03-03 22:31","pubTimestamp":1741012318,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines Inc reports results for the quarter ended December 31 - Earnings SummaryPraxis Precision Medicines Inc PRAX.OQ reported a quarterly adjusted loss of $2.94 per share for the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nL5N3PM18Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRAX"],"gpt_icon":0},{"id":"2516633036","title":"Praxis Precision price target lowered to $85 from $150 at Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2516633036","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516633036?lang=en_us&edition=full_marsco","pubTime":"2025-03-03 21:05","pubTimestamp":1741007151,"startTime":"0","endTime":"0","summary":"Needham lowered the firm’s price target on Praxis Precision (PRAX) to $85 from $150 and keeps a Buy rating on the shares. The firm is removing Ulix...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/praxis-precision-price-target-lowered-to-85-from-150-at-needham?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/praxis-precision-price-target-lowered-to-85-from-150-at-needham?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PRAX"],"gpt_icon":0},{"id":"2516168633","title":"Praxis Precision Medicines Inc : Needham Cuts Target Price to $85.00 From $150.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2516168633","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516168633?lang=en_us&edition=full_marsco","pubTime":"2025-03-03 21:03","pubTimestamp":1741007019,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nFWN3PM134:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PRAX"],"gpt_icon":0},{"id":"2516638546","title":"Deutsche Bank Adjusts Praxis Precision Medicines Price Target to $65 From $111, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2516638546","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516638546?lang=en_us&edition=full_marsco","pubTime":"2025-03-03 20:37","pubTimestamp":1741005469,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines (PRAX) has an average rating of Buy and mean price target of $99.27, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MDCO","PRAX","DB"],"gpt_icon":0},{"id":"2516213680","title":"Praxis Precision Med Is Maintained at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2516213680","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516213680?lang=en_us&edition=full_marsco","pubTime":"2025-03-03 20:13","pubTimestamp":1741003980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRAX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 03, 2025 07:13 ET (12:13 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRAX"],"gpt_icon":0},{"id":"2516687438","title":"Praxis Precision Medicines, Inc.  : Deutsche Bank Cuts Target Price to $65 From $111","url":"https://stock-news.laohu8.com/highlight/detail?id=2516687438","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516687438?lang=en_us&edition=full_marsco","pubTime":"2025-03-03 20:03","pubTimestamp":1741003387,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nAQN2K45ZX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRAX","BK4139"],"gpt_icon":0},{"id":"2516682152","title":"Praxis Precision Medicines Inc : Guggenheim Cuts Target Price to $120 From $170","url":"https://stock-news.laohu8.com/highlight/detail?id=2516682152","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516682152?lang=en_us&edition=full_marsco","pubTime":"2025-03-03 19:42","pubTimestamp":1741002136,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nFWN3PM0JA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRAX","BK4139"],"gpt_icon":0},{"id":"2516150651","title":"U.S. RESEARCH ROUNDUP- Autodesk, Fedex, Morgan Stanley Direct Lending Fund","url":"https://stock-news.laohu8.com/highlight/detail?id=2516150651","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516150651?lang=en_us&edition=full_marsco","pubTime":"2025-03-03 15:43","pubTimestamp":1740987813,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Autodesk, Fedex, Morgan Stanley Direct Lending Fund March 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nL3N3PM0FA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z9Z06.USD","WTS","LU2125910336.SGD","LU2326559502.SGD","LU1721428933.USD","BK4088","IE00B2PGVK34.USD","FSS","BK4096","LU2087621335.USD","LU1992135399.USD","LU0345774631.USD","LU0889565916.HKD","UHS","LU1978683503.SGD","LU2265009873.SGD","FDX","PUBM","GILD","BK4185","CABO","FOXF","LU0323240290.USD","PRAX","DCBO","ASTH","IE00BZ9MQY76.HKD","GEV","ARDT","LU1066051498.USD","BK4568","LU0289739699.SGD","LU0054578231.USD","BK4578","LU2065731478.USD","LU2298064838.USD","MSDL","VTR","ADSK","LU0251142724.SGD","HUBB","GTLS","LU0724618433.USD","IE00B66KJ199.SGD","BK4131","IE00B3T34201.USD","IE00BN0W2W23.USD","BLD","BJ"],"gpt_icon":1},{"id":"2516579417","title":"Praxis Precision Medicines Inc : Jefferies Cuts Target Price to $105 From $305","url":"https://stock-news.laohu8.com/highlight/detail?id=2516579417","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516579417?lang=en_us&edition=full_marsco","pubTime":"2025-03-03 12:45","pubTimestamp":1740977125,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nFWN3PM036:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PRAX"],"gpt_icon":0},{"id":"2516092013","title":"Sector Update: Health Care Stocks Rise in Late Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2516092013","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516092013?lang=en_us&edition=full_marsco","pubTime":"2025-03-01 04:51","pubTimestamp":1740775864,"startTime":"0","endTime":"0","summary":"Health care stocks rose late Friday afternoon, with the NYSE Health Care Index up 0.5% and the Health Care Select Sector SPDR Fund  adding 0.7%.The iShares Biotechnology ETF  was 0.9% higher.In corporate news, BioXcel Therapeutics  shares jumped 24% after the company regained compliance with Nasdaq's minimum closing bid price rule.Owens & Minor  shares surged 40% after it reported better-than-expected quarterly results and a share buyback plan Friday.DocGo  shares fell past 21% after the company reported a Q4 net loss, surprising analysts who expected a profit.Praxis Precision Medicines  shares dropped 41%. An independent data monitoring committee overseeing the company's study 1 of the Essential3 program of ulixacaltamide in essential tremor recommended that the study be \"stopped for futility.\"","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRAX","BK4139","BK4581","DCGO","BK4175","BK4196","BK4588","BTAI","XLV","BK4585","IBB","OMI"],"gpt_icon":0},{"id":"2516063643","title":"Positive Outlook on Praxis Precision Medicines Amidst Phase 3 ET Program Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2516063643","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516063643?lang=en_us&edition=full_marsco","pubTime":"2025-03-01 04:05","pubTimestamp":1740773118,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Ritu Baral maintained a Buy rating on Praxis Precision Medicines (PRAX – Research Report) today and set a price target of $61.00. ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/positive-outlook-on-praxis-precision-medicines-amidst-phase-3-et-program-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/positive-outlook-on-praxis-precision-medicines-amidst-phase-3-et-program-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4561","BK4581","BK4590","BK4588","BK4139","ET","PRAX","BK4144","MDCO","BK4585"],"gpt_icon":0},{"id":"2516318306","title":"Praxis Precision downgraded to Underperform from Neutral at Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2516318306","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516318306?lang=en_us&edition=full_marsco","pubTime":"2025-03-01 03:55","pubTimestamp":1740772532,"startTime":"0","endTime":"0","summary":"Wedbush analyst Laura Chico downgraded Praxis Precision (PRAX) to Underperform from Neutral with a $26 price target Published first on TheFly – the...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/praxis-precision-downgraded-to-underperform-from-neutral-at-wedbush?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/praxis-precision-downgraded-to-underperform-from-neutral-at-wedbush?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRAX","BK4139"],"gpt_icon":0},{"id":"2516796308","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2516796308","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516796308?lang=en_us&edition=full_marsco","pubTime":"2025-03-01 03:04","pubTimestamp":1740769443,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines (PRAX) said Friday it received a recommendation from an independent data monitoring committee overseeing its study 1 of the so-called Essential3 program of ulixacaltamide in","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DV","NTAP","PRAX","BK4585","BK4139","LU0203345920.USD","LU0203347892.USD","BK4539","BK4170","SG9999001440.SGD","BK4023","BK4588"],"gpt_icon":0},{"id":"2516337732","title":"Praxis Precision Medicines: Navigating Challenges and Catalysts in Epilepsy Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2516337732","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516337732?lang=en_us&edition=full_marsco","pubTime":"2025-03-01 01:25","pubTimestamp":1740763515,"startTime":"0","endTime":"0","summary":"Douglas Tsao, an analyst from H.C. Wainwright, reiterated the Buy rating on Praxis Precision Medicines (PRAX – Research Report). The associated pri...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/praxis-precision-medicines-navigating-challenges-and-catalysts-in-epilepsy-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/praxis-precision-medicines-navigating-challenges-and-catalysts-in-epilepsy-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRAX","MDCO"],"gpt_icon":0},{"id":"2516773143","title":"H.C. Wainwright sees opportunity for quick rebound from Praxis after setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2516773143","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516773143?lang=en_us&edition=full_marsco","pubTime":"2025-03-01 01:20","pubTimestamp":1740763208,"startTime":"0","endTime":"0","summary":"H.C. Wainwright tells investors that the firm’s investment thesis on Praxis Precision (PRAX) Medicines has been based on the company’s “innovative”...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/h-c-wainwright-sees-opportunity-for-quick-rebound-from-praxis-after-setback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/h-c-wainwright-sees-opportunity-for-quick-rebound-from-praxis-after-setback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRAX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.praxismedicines.com","stockEarnings":[{"period":"1week","weight":0.0751},{"period":"1month","weight":-0.5711},{"period":"3month","weight":-0.4668},{"period":"6month","weight":-0.3444},{"period":"1year","weight":-0.294},{"period":"ytd","weight":-0.4942}],"compareEarnings":[{"period":"1week","weight":0.0117},{"period":"1month","weight":-0.0698},{"period":"3month","weight":-0.0615},{"period":"6month","weight":0.0102},{"period":"1year","weight":0.1124},{"period":"ytd","weight":-0.0323}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is developing ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase IIb clinical trial for the treatment of essential tremor, as well as in Phase II clinical trial to treat Parkinson's disease; PRAX-562 for the treatment of pediatric patients with developmental and epileptic encephalopathies (DEE); and PRAX-628 to treat focal epilepsy. The company also develops PRAX-222 for the treatment of pediatric patients with early-onset SCN2A-DEE; PRAX-020 to treat KCNT1 related epilepsies; PRAX-080 for the treatment of PCDH19; and PRAX-090 and PRAX-100 for SYNGAP1 and SCN2A-LoF. It has a license agreement with RogCon Inc.; a research collaboration and license agreement with Ionis Pharmaceuticals, Inc.; a strategic collaboration and license agreement with UCB Biopharma SRL; and collaboration with The Florey Institute to develop three novel ASOs. Praxis Precision Medicines, Inc. was incorporated in 2015 and is based in Boston, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.344924},{"month":2,"riseRate":0.2,"avgChangeRate":-0.21435},{"month":3,"riseRate":0.4,"avgChangeRate":-0.178121},{"month":4,"riseRate":0.25,"avgChangeRate":-0.021503},{"month":5,"riseRate":0.25,"avgChangeRate":-0.16117},{"month":6,"riseRate":0.25,"avgChangeRate":-0.140675},{"month":7,"riseRate":0.5,"avgChangeRate":0.137618},{"month":8,"riseRate":0.5,"avgChangeRate":0.140814},{"month":9,"riseRate":0.5,"avgChangeRate":-0.024007},{"month":10,"riseRate":0.5,"avgChangeRate":-0.047129},{"month":11,"riseRate":0.8,"avgChangeRate":0.090487},{"month":12,"riseRate":0.8,"avgChangeRate":0.147899}],"exchange":"NASDAQ","name":"Praxis Precision Medicines, Inc.","nameEN":"Praxis Precision Medicines, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.31.7","shortVersion":"4.31.7","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Praxis Precision Medicines, Inc.(PRAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Praxis Precision Medicines, Inc.(PRAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Praxis Precision Medicines, Inc.,PRAX,Praxis Precision Medicines, Inc.股票,Praxis Precision Medicines, Inc.股票老虎,Praxis Precision Medicines, Inc.股票老虎国际,Praxis Precision Medicines, Inc.行情,Praxis Precision Medicines, Inc.股票行情,Praxis Precision Medicines, Inc.股价,Praxis Precision Medicines, Inc.股市,Praxis Precision Medicines, Inc.股票价格,Praxis Precision Medicines, Inc.股票交易,Praxis Precision Medicines, Inc.股票购买,Praxis Precision Medicines, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Praxis Precision Medicines, Inc.(PRAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Praxis Precision Medicines, Inc.(PRAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction